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Background: The morbidity of pancreatic resection remains high, with pancreatic fistula being the most common cause.
The important question is whether any postoperative treatment adjustment may prevent the development of clinically
significant postoperative pancreatic fistulae. Recent studies have shown that intraabdominal drains and manipulation
using them are of great importance. Although authors of a few retrospective reports have described good results of
pancreatic resection without the use of intraabdominal drains, a recent prospective randomized trial showed that routine
elimination of drains in pancreaticoduodenectomy is associated with poor outcome. An important issue arises as to
which type of drain is most suitable for pancreatic resection. Two types of surgical drains exist: open drains and closed
drains. Open drains are considered obsolete nowadays because of frequent retrograde infection. Closed drains include
two types: passive gravity drains and closed-suction drains. Closed-suction drains are more effective, as they remove fluid
from the abdominal cavity under light pressure. However, some surgeons believe that closed-suction drains represent a
potential hazard to patients and that negative pressure might increase the risk of pancreatic fistulae. Nobody has yet
specifically dealt with the question of which kind of drainage is most appropriate in pancreatic surgery.
Methods/Design: The aim of the DRAins in PAncreatic surgery (DRAPA) trial is to compare the closed-suction
drain versus the closed passive gravity drain in pancreatic resection. DRAPA is a dual-centre, prospective,
randomized controlled trial. The primary endpoint is the rate of postoperative pancreatic fistula; the secondary
endpoint is postoperative morbidity with follow-up of 3 months.
Discussion: No study to date has compared different types of drains in pancreatic surgery. This study is
designed to answer the question whether any particular type of drain might lower the rate of postoperative
pancreatic fistula or other complications.
Trial registration: ClinicalTrials.gov Identifier: NCT01988519. Registered 13 November 2013.
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Pancreatic resection is the only potentially curative method
for treatment of pancreatic neoplasms. These surgical pro-
cedures are technically demanding, with pancreaticoduode-
nectomy and distal pancreatectomy being the most
common [1]. Although the mortality rate associated with
these procedures has dropped to under 5% in recent de-
cades, the morbidity remains high [2,3]. The most signifi-
cant and ominous complication is the postoperative
pancreatic fistula (POPF) [4]. Although this complication is
in most cases not life-threatening, it prolongs the hospital
stay and requires additional treatment (for example with
antibiotics, nutritional support) and interventions (such as
endoscopy, interventional radiology and/or reoperation)
and thus increases the cost of the treatment [2,5]. Accord-
ing to the International Study Group of Pancreatic Fistula
(ISGPF) consensus definition, pancreatic fistula is diag-
nosed if the amylase content in fluid from the intraabdom-
inal drains exceeds three times the normal serum
concentration [6].
Several methods have been studied in the past with
the goal of lowering the pancreatic fistula rate. They in-
clude pharmacological prophylaxis with octreotide [7]
and various technical modifications of pancreatic
remnant management after pancreaticoduodenectomy
[8,9] and after distal pancreatectomy [10]. However, the
use of octreotide remains controversial, and none of the
studied techniques proved to be superior.
Another method of influencing the rate of pancreatic
fistulae and postoperative complications is the use of
intraabdominal drains and manipulation with them. Re-
cent studies show that the use of drains, the type of
drain and the manipulation with the drain can lower the
pancreatic fistula rate [11-13].
Intraabdominal drains have traditionally been used in
surgical fields [14]. The main significance of the drains
is to prevent formation of intraabdominal fluid collec-
tion; furthermore, it helps with early diagnosis of post-
operative bleeding, pancreatic and biliary leak, or
anastomotic dehiscence [15-17]. In some cases, keeping
the drain in place for a longer period of time can be part
of conservative treatment of the pancreatic fistula, such
as by creating a controlled pancreaticocutaneous fistula
until the fistula has healed spontaneously without any
additional treatment [11,18].
Recent studies show that the use of drains might not be
beneficial for the patient, such as in cholecystectomy, ap-
pendicectomy, gastric resection, bowel resection and liver
resection [19]. Moreover, the use of drains might even be
harmful for the patient, as it can slow down recovery and
the restoration of bowel movements and can prolong the
hospital stay or even cause postoperative complications
such as retrograde intraabdominal infection, hollow organ
perforation and/or loss of fluid and electrolytes.Pancreatic surgery is different from surgery of hollow
organs. Unlike enteric anastomotic dehiscence, which
often presents with pneumoperitoneum and frequently
causes peritonitis [20], pancreatic leak is more frequent,
but the clinical course is not usually so dramatic [4].
Pancreatic leak or pancreatic fistulae can be easily diag-
nosed by analysing the amylase concentration in the
drain effluent [21]. However, the amylase concentration
is increased in the majority of patients on the first post-
operative day, even in those patients who do not develop
pancreatic fistulae in the postoperative course. This
means that the pancreatic anastomosis is not ‘watertight’
in the majority of the patients [22].
The important question is whether any treatment ad-
justment in the postoperative course may prevent the
development of clinically significant POPF. Recent stud-
ies have shown that intraabdominal drains and the ma-
nipulation with them are of great importance [11,13,23].
Three important questions arise when studying drains in
pancreatic surgery:
1. Is it necessary to use drains following pancreatic
resection?
2. When should the drains be removed?
3. Which type of intraabdominal drain is most
suitable?
These questions are addressed in turn in the subsec-
tions below.
Is it necessary to use drains following pancreatic
resection?
Drains have traditionally been used in abdominal surgery in
most procedures, including pancreatic resection. The first
pilot study describing the results of pancreaticoduodenect-
omy in 22 patients without drains was published in 1992
[24]. A number of retrospective cohort studies have shown
superior results of pancreatic resection without routine
intraabdominal drainage [13], but only two randomized
studies compared pancreatic resection with versus without
drains. The first randomized controlled trial was conducted
in Memorial Sloan Kettering Cancer Center in New York
City [14]. It failed to show that surgically placed intraab-
dominal drains reduce the rate of complications.
In a recent study, Van Buren et al. showed level I evi-
dence that elimination of routine drainage in all cases of
pancreaticoduodenectomy results in unacceptably poor
outcomes, and thus this approach cannot be recom-
mended [25]. Further studies are needed to confirm
these results.
When should the drains be removed?
Two studies have addressed this question. In one retro-
spective study, researchers compared removal of the
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tors in a prospective randomized trial compared removal
of drains on day 3 versus after day 5 in patients with low
risk of POPF [15]. Both studies showed a lower rate of
intraabdominal complications and fluid collections, and
a lower rate of POPF, in the group with early drain
removal.
Which type of intraabdominal drain is most suitable?
The final issue regarding drains in pancreatic surgery is
which type of drain to use. Two types of surgical drains
exist: open drains and closed drains. Open drains are
considered obsolete because their use is associated with
frequent retrograde infection [27]. Closed drains include
two types: passive gravity drains and closed-suction
drains. Generally speaking, closed-suction drains are pre-
ferred in the United States [28,29], and passive gravity
drains are used more frequently in Europe [30]. Only two
studies have compared the different types of drains: the
Penrose drain versus closed-suction drain [31,32]. However,
these two studies were retrospective and conducted over a
long period of time (17 years and 22 years, respectively);
comparison of the drains was not the primary endpoint;
and the studies’ results are contradictory. Nobody has spe-
cifically dealt with the question of which kind of drainage is
more appropriate in pancreatic surgery [12]. Diener et al.,
in a systematic review of the current state of evidence for
drains in pancreatic surgery, stated that the role of different
types of drains remains unclear [11].
Methods/Design
Objectives and hypothesis
The aim of the DRAins in PAncreatic surgery (DRAPA)
trial is to compare two types of intraabdominal drains in
pancreatic resection and their effect on the development
of POPF and postoperative complications. Closed-
suction drains are more effective, as they remove fluid
from the abdominal cavity under light negative pressure
[13]. However, some surgeons believe that closed-
suction drains represent a potential hazard to patients
[33] and that negative pressure might increase the risk
of POPF [13].
The following hypotheses will be tested:
H0: The risk of development of POPF and
postoperative complications is equal in both groups.
H1: The risk of development of POPF and
postoperative complications is different between the
groups.
Study population and eligibility criteria
The DRAPA trial will encompass two participating cen-
tres: University Hospital Hradec Králové and University
Hospital Olomouc, both in the Czech Republic. Allpatients who are scheduled for pancreatic resection at
the two participating centres will be screened and
assessed for eligibility.
Only patients who undergo pancreaticoduodenectomy
or distal pancreatic resection will be included in the
study. Patients with nonstandard procedures or a pro-
cedure associated with higher morbidity will be excluded
from the study to achieve a homogeneous study group.
Detailed inclusion and exclusion criteria are described
below.
Inclusion criteria
1. Patients scheduled for primary
pancreaticoduodenectomy or distal pancreatic
resection in participating centres
2. Aged 18 years or older
3. Signed informed consent provided
Exclusion criteria
1. No pancreatic resection performed: nonresectable
tumour




5. Resection of the portal vein and reconstruction with
a graft
6. Lack of compliance, informed consent not provided
or refusal to participate
Sample size calculation
The sample size calculation is based on the expected
rate of POPF from our previous experience, as there
exist no pilot data comparing the closed-suction drain
and closed passive gravity drain in pancreatic surgery.
The POPF rate in the closed passive gravity drain group
is expected to be 35% based on previous studies [2,3].
The POPF rate in the closed-suction drain group is ex-
pected to drop to half that rate (17.5%). The sample size
calculation is based on a one-sided t-test for differences
with respect to the primary endpoint, which is the POPF
rate. With α= 5% and β = 20%, a sample size of 97 pa-
tients per group is necessary to detect a difference be-
tween the groups. With an expected dropout rate of
15%, we plan to enrol 223 patients into the study.
Ethics, study registration and consent
This trial was approved by independent ethics commit-
tees at both participating institutions: the University
Hospital Hradec Králové (registration number 201308
S27P) and the University Hospital Olomouc (registration
number 129/13). The DRAPA trial will be conducted in
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with the Declaration of Helsinki. The trial is registered
at ClinicalTrials.gov under the registration number
NCT01988519. All patients who are scheduled for pan-
creatic resection in participating institutions will be
screened for eligibility and informed in detail about the
DRAPA trial. Informed consent will be obtained from
each participant. The study procedures, risks, benefits
and data management will be clarified with the patients
before they are asked to give their informed consent to
participate.Study treatment
The surgical technique is standardized in both partici-
pating institutions and has been described previously
[2]. Standard resection of the pancreatic head with
duodenum is performed, followed by the reconstruc-
tion phase. A jejunum limb is prepared and brought
through the transverse mesocolon for the pancreatic
and biliary anastomosis. Pancreaticojejunostomy is
performed in end-to-side fashion. No stents are used.
No additional manipulation, such as fibrin glue or
reinforcement with meshes, is allowed. The end-to-
side hepaticojejunostomy is made in a single layer of
interrupted stitches about 15 cm distal from the pan-
creaticojejunostomy. End-to-side duodenojejunostomy
is performed about 50 cm distally in the antecolic pos-
ition. For distal pancreatectomy, after exploration of
the abdominal cavity, the pancreas is exposed and
transected by scalpel in a fish mouth fashion. A splen-
ectomy is performed according to the surgeon’s discre-
tion based on the benign or malignant nature of the
tumour. The main pancreatic duct is occluded with a
crossing stitch. The pancreatic remnant is then closed
with interrupted stitches. In pancreaticoduodenect-
omy, two drains are placed: one in front of and one
behind the pancreatic anastomosis. In distal pancrea-
tectomy, one drain is placed near the pancreatic
remnant. A second drain is placed in the left subphre-
nic area only when splenectomy is performed.
In patients assigned to the closed passive gravity drain-
age group, passive tube drains (pfm medical, Cologne,
Germany) are used. In patients assigned to the closed-
suction drain group, BLAKE silicone drains (Ethicon
Endo-Surgery, Cincinnati, OH, USA) are used. Drains
are pulled through a separate stab incision outside the
laparotomy and fixed with a stitch to the skin. The vol-
ume of the fluid is measured every 24 hours and noted
in the patient’s record form. Amylase content in the
drain fluid is analysed every other day starting on the
third postoperative day until removal of the drain.
Drains are removed between day 4 and day 6 after the
surgery if no POPF develops.Safety aspects
Pancreatic resection is a highly technically demanding
procedure. High-volume surgeons with great experience
have better results than low-volume surgeons with less
experience [34]. In order to avoid bias based on the
learning curve of the surgeons, every surgical procedure
will be performed or supervised by a senior surgeon who
has experience with at least 50 pancreatic resections. In-
sertion of both types of drain is a simple common pro-
cedure performed on a routine basis, and no special
training is necessary and no complications are expected.
Postoperative data collection
A daily visit of the study patients will be made by
clinical investigators or a delegated physician. All
protocol-required information collected during the
trial will be entered into the patient’s record form.
Preoperative data gathered include patient sex, age,
body mass index, American Society of Anesthesiolo-
gists physical status classification system score and
comorbidities, especially those considered to increase
the risk of POPF (diabetes mellitus and ischaemic
heart disease) [35,36]. Intraoperative data to be col-
lected include surgery duration, estimated blood loss,
diameter of the main pancreatic duct and pancreatic
gland texture. The diameter of the main pancreatic
duct will be measured with a set of probes. Postoper-
ative data to be gathered include volume of the drain
output measured every 24 hours, amylase content
analysed every other day starting on day 3, and the
day of drain removal. Laboratory tests will include
serum amylase, C-reactive protein, bilirubin and
leukocyte count on days 3 and 7 [37]. Postoperative
course assessments will include duration of intensive
care, hospital stay including readmissions for postop-
erative complications, reinterventions (reoperations,
endoscopy and interventional radiology procedures)
and the reasons for readmissions. All the patients will
have undergo ultrasonography or computed tomog-
raphy (CT) before discharge from the hospital to de-
tect any fluid collections. The patients will be seen by
a clinical investigator 6 weeks and 3 months after the
surgery in the outpatient department.
Primary and secondary endpoints
The primary endpoint of this study is the rate of POPF
occurrence. POPF is defined by the ISGPF as any meas-
urable volume of drain fluid on or after postoperative
day 3 with amylase content greater than three times the
normal upper serum value [6]. Three grades of POPF
are determined according to clinical severity: A, B and
C.
Grade A POPF, also called ‘transient fistula’, has no
clinical impact. The patient’s clinical condition is good,
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quired. Hospital discharge is not delayed. The drains are
usually removed within 3 weeks.
Grade B POPF is symptomatic and clinically apparent,
and peripancreatic collections may occur. Changes in
clinical management are required, such as nutritional
support, as well as antibiotics in cases of infection, and
new drains into the collections may be inserted. Hospital
stay is usually delayed, or readmission may be required.
Grade C POPF is severe and clinically significant. The
clinical condition of the patient is poor, and stability
may be borderline. Major changes in clinical manage-
ment are required, such as intensive care, CT-guided
drainage of peripancreatic collections or reoperation.
The secondary endpoint is the postoperative mor-
bidity, including wound infection, intraabdominal col-
lections, delayed gastric emptying, postoperative
haemorrhage, pneumonia, abdominal rupture, cardiac
events and neurological complications (Table 1), as
previously defined [5,30,38-41]. Postoperative compli-
cations are graded based on severity according to the
Clavien-Dindo definition as modified by DeOliveira
and colleagues for pancreatic surgery [42,43] (Table 2).Methods for avoiding bias
Minimizing systemic bias
Patients will be randomized to one of the drain groups
during the surgical procedure after resectability of theTable 1 Clinical parameters and postoperative complications
Parameters Definitions
Hospital stay Days from initial operation to hospital discharge p
Operating time Time from skin incision to wound closure (minute
Delayed gastric
emptying
Failure to resume solid diet with prolonged need
Biliary leak Bilirubin concentration in the drain fluid at least th
Postoperative
haemorrhage
Evidence of blood loss from drains and/or nasoga
Intraabdominal fluid
collection
Collection of fluid measuring ≥3 cm associated w
Symptomatic
fluidothorax
Fluid in the pleural cavity associated with respirato
Abdominal rupture Dehiscence of abdominal closure with need for re
Myocardial infarction Increase of serum concentration of CK-MB and tro
duration, new persistent ST elevation and/or depr
Pneumonia Presence of a new infiltrate on chest X-ray, as wel
or positive sputum, and requiring antibiotic treatm
Acute renal failure Serum creatinine >3.0 mg/dl and/or need for dial
Wound infection Surgical site infection associated with laparotomy
Urinary tract infection Culture-positive urine, pyuria or bacteriuria on urin
aCK-MB, Creatine kinase MB isoenzyme; ECG, Electrocardiogram; ISGLS, Internationa
Surgery; WBC, White blood cells.tumour is confirmed. Randomization will be accom-
plished using balanced permutation blocks by generation
of random numbers in order to obtain homogeneity be-
tween groups. Patients scheduled for pancreaticoduode-
nectomy and distal pancreatectomy will be randomized
separately, as these two procedures are different with re-
gard to the course and consequences of POPF [25,44].
Opaque, sealed envelopes will be produced, labelled with
the randomization number and containing a sheet that
states the group allocation for the patient. Randomization
envelopes will be used in consecutive order. Basic charac-
teristics of the patient and the day of randomization will be
documented on a data sheet so that compliance to the
randomization scheme may be checked retrospectively. If
patients are excluded from the study after randomization,
their numbers will not be reused. Obviously, operating sur-
geons, attending physicians and nursing staff cannot be
blinded, as the drains look different. However, outcome as-
sessors will be blinded. The randomization process will fol-
low the CONSORTguidelines (Figure 1) [45].Minimizing treatment bias
Pancreatic resection is standardized in both participating
centres. Both types of drain are used in the participating
departments; all surgeons participating in the study are
familiar with them. Insertion of both types of drain is a
simple, common procedure performed on a routine
basis, which eliminates a learning curve.for analysisa
lus any readmission within 30 days
s)
for nasogastric tube as defined by ISGPS [40]
ree times the serum bilirubin concentration as defined by ISGLS [38]
stric tube, based on ultrasonography, as defined by ISGPS [41]
ith clinical or laboratory abnormalities
ry distress or a need to evacuate the fluid
suture of the laparotomy during the initial hospital stay
ponin and/or the following ECG changes: new Q waves ≥0.04 in
ession
l as the following: body temperature >38°C, abnormal elevation of WBC,
ent
ysis
that develops during the initial hospital stay
alysis requiring antibiotic treatment
l Study Group of Liver Surgery; ISGPS, International Study Group for Pancreatic
Table 2 Complication grades according to the Dindo-DeOliveira classification schemea
Grade Definition
Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and
radiologic intervention
Grade II Requiring pharmacological treatment with drugs other than those allowed for grade I complications
Grade III Requiring surgical, endoscopic or radiological intervention
Grade IIIa Intervention not under general anaesthesia
Grade IIIb Intervention under general anaesthesia
Grade IV Life-threatening complications requiring intensive care unit management




Grade V Death of patient
aThe Dindo-DeOliveira classification system is reported in detail elsewhere [42,43].
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Detection and grading of POPF and postoperative com-
plications, which are the primary and secondary end-
points, will be based on data in the patient’s record
form. Blinding is not necessary, because the occurrence
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Figure 1 Flowchart of the process of the phases of the randomized trial acinfluenced by the patient. Physician blinding is not pos-
sible, because the drains are apparently different.
Statistical methods
Each patient’s allocation to the analysed population will
be defined prior to the analysis and will be documented.ssed for 
ty
Patients excluded: 
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cording to the CONSORT guidelines.
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domized according to the intention-to-treat principle.
The intention-to-treat principle implies that the analysis
includes all randomized patients. The per-protocol ana-
lysis set will include all the patients without major
protocol deviation. Deviations from the protocol will be
assessed as major or minor. Patients with major devia-
tions from the protocol will be excluded from the per-
protocol analysis. The safety analysis set will analyse
patients according to the treatment.
The null hypothesis assumes that the risk of de-
velopment of POPF and postoperative complications
is equal in both groups. A binary logistic regression
will be applied in order to compare POPF in the
groups adjusting for other factors. Two-tailed t-tests
or nonparametric Mann–Whitney U tests will be
applied for continuous secondary endpoints. χ2 tests
or Fisher’s exact test will be used for analysis of
categorical secondary endpoints. A P-value <0.05
will be considered statistically significant. Statistical
analyses will be performed using NCSS statistical
software (NCSS, Kaysville, UT, USA).Discussion
Despite growing evidence in favour of pancreatic resec-
tion without intraabdominal drainage [13], routine elim-
ination of drains cannot be recommended [25]. Rather
more, drains could diminish the rate and severity of
POPF in patients with high risk of POPF. Drains could
possibly be avoided in patients with low risk of POPF
[46]. However, the majority of pancreatic surgeons still
consider routine placement of intraabdominal drains
mandatory [15-17]. Once a decision is made to use
intraabdominal drains, a controversy remains about
which type of drain is most suitable in pancreatic resec-
tion [47]. Two types of drains are commonly used now-
adays: passive gravity drains [26,30] and closed-suction
drains [28,29]. Closed-suction drains are more effective,
as they remove fluid from the abdominal cavity under
light negative pressure [13]. However, some surgeons be-
lieve that closed-suction drains represent a potential
hazard to patients [33] and that negative pressure might
increase the risk of POPF [13]. No study conducted to
date has specifically addressed the question of which
type of drain is most beneficial for patients [12,13].
The DRAPA trial is designed to compare closed-
suction drains with passive gravity drains in pancreatic
surgery. Using the ISGPF definition of POPF will allow
us to compare the results of this trial with those of other
trials of drains in pancreatic surgery. This trial can show
whether closed-suction drains represent hazards to pa-
tients or are beneficial in terms of decreasing POPF
rates.Trial status
The DRAPA trial is currently recruiting patients. The
last patient is expected to be recruited by December
2015.
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